Objectives: [ 11 C]PHNO is a D3/D2 agonist radioligand with preferential affinity for D3 receptors. As the [ 11 C]PHNO pinding potential (BP ND ) is a mixture of D3 and D2 signal, assessment of the D3 component of [ 11 C]PHNO binding relies on regional differences in D3 and D2 receptor numbers. 1 A robust delineation of regions of interest (ROI) with a relatively homogenous proportion of D3:D2 receptors is therefore important for accurate quantification of the components of [ 11 C]PHNO binding. We report the development of robust criteria to define ROI for the analysis of human [ 11 C]PHNO scans. Both manual and automated definitions of these ROI are evaluated and the reproducibility and accuracy of these methods are assessed. Methods: The striatum (ST) was subdivided into 6 subregions incorporating information from connectivity/autoradiography studies and the distribution of [ 11 C]PHNO. Putamen (PU) was subdivided into precommissural dorsal/ventral (preDPU, preVPU) and postcommisural (posPU). Caudate (CD) was divided into precommissural/postcommisural (preCD, posCD), while accumbens and the medial-ventral parts of PU and CD were designated as ventral-striatum (VST). ST and globus-pallidus (GP) ROI were delineated on T1-MR images. Substantia-nigra (SN) was defined on PET integral images using a fixed-size ROI. [ 11 C]PHNO PET and T1-MR images from 12 subjects were analysed. Each subject's PET data was motion corrected and coregistered to their T1-MR image. ROI were defined using three different approaches: I. Manual definition of regions on two occasions ( > one month apart), II. Manual definition of regions according to a previously published method developed for raclopride 2 to provide a benchmark for reproducibility, III. Automated definition using a nonlinear deformation of regions defined on the MNI_T1 template according to the criteria in Method I (except SN). Time activity curves (TAC) were derived and SRTM was applied with cerebellum as reference region to determine regional BP ND estimates. ROI volume overlap (DICE) and BP ND variability (VAR BP ), were assessed for; (i) intra-operator repro-ducibility for Methods I and II, (ii) inter-method agreement for Methods I and III. Results: The average inter-subject BP ND values, obtained with Method I, in order of magnitude are, GP = 3.0 ± 0.4, VST = 2.9 ± 0.3, preVPU = 2.7 ± 0.2, pre-DPU = 2.3 ± 0.2, posPU = 2.2 ± 0.1 preCD = 1.9 ± 0.2 SN = 1.6±0.3 and posCD = 1.3±0.2.
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Intra-operator agreement was high for volume overlap and BP ND for both Methods I and II (DICE; Method I: preCD = 91±1%, posCD = 85±2%, pre-DPU = 92±2%, preVPU = 92±1%, posPU = 91±2%, VST = 89 ± 2%, GP = 85 ± 3% and SN = 80 ± 13%, Method II: preCD = 89 ± 5%, posCD = 82 ± 5% pre-PU = 89±2%, posPU = 86±4% and VST = 78±3%. VAR BP ; Method I: preCD=0.9 ± 1%, posCD = 3.8 ± 2.3%, preDPU = 2.7 ± 1.3%, preVPU = 1.6 ± 0.71%, pos-PU = 1.7±1.6%, VST = 1.4±1%, GP = 3.1±2.0% and SN = 5 ± 4%, Method II: preCD = 1.2 ± 1%, posCD = 4 ± 4% prePU = 1 ± 1%, posPU = 1 ± 1% and VST = 2±1%).
The agreement between Methods I and III was generally good. (DICE: preCD = 75 ± 4%, posCD = 56 ± 16%, preDPU = 65 ± 11%, preVPU = 74 ± 9%, pos-PU = 58±13%, GP = 76±6%, VST = 67±10%, VAR BP ; preCD = 6.4 ± 4%, posCD = 7.3 ± 6.2%, preDPU = 4.4 ± 2.8%, preVPU = 5.9 ± 4.5%, posPU = 3.3 ± 3.4%, VS-T = 5.8±6%, GP = 4.9±4.5%). Note that the lower DICE coefficients for the posCD and posPU are not reflected in those for the gross regions (DICE: CD = 76±4%, PU = 77±8%). Conclusions: The criteria developed for the analysis of [ 11 C]PHNO scans provide robust and reproducible results for the manual delineation of ROI. The automated ROI, approach the performance of the manual at the level of CD, PU and VST.
160. Off-line motion correction methods for multi-frame PET data Background and aims: Patient motion during PET acquisition may reduce spatial resolution and alter time-activity curves, especially for small region of interests, thereby affecting outcome of tracer kinetic analyses. Currently, on-line optical motion tracking systems are available. 1, 2 Although these systems show some important advantages, e.g. in-frame motion correction, there are also some drawbacks. First, old datasets, scanned without an on-line motion tracking system, cannot be corrected. Second, most on-line motion tracking systems require that PET data to be acquired in list-mode, which is not possible on older scanners. Third, application of these systems is not always possible due to limited view within the gantry in case of auxiliary equipment. Off-line (mathematical) motion correction methods do not have these disadvantages. Aim of the present study was to evaluate several off-line frame-by-frame motion correction methods for correcting patient motion. Methods: Four different motion correction methods were evaluated. They differed in the way realignment parameters were derived, based on:
(1) sum of first x frames of normal PET scan, (2) sum of first x frames of non-attenuation corrected PET scan, (3) attenuation map and (4) attenuation map divided by measured attenuation correction factors.
In method 2 to 4 realignment was included in a final image reconstruction process to correct for attenuation and emission mismatch as well. Two simulation studies were performed, based on [ 11 C]flumazenil and [ 11 C]PK11195 datasets, respectively. In both simulation studies kind (rotation, translation) and amount of motion were varied. Simulated PET scans were corrected for motion using all four correction methods. Next, optimal settings derived from the simulation studies were used to evaluate two clinical datasets each of [ 11 C]flumazenil, [ 11 C]PK11195 and [ 11 C]PIB. For the clinical datasets, volume of distribution (V T ) values, obtained with Logan analysis, 3 were compared before and after motion correction. Results: Optimal results were obtained when realignment parameters were based on method 2, where differences in regional V T values were < 2.8% and < 3.5% for [ 11 C]flumazenil and [ 11 C]PK11195 simulation studies, respectively. In comparison, differences up to 22%, 62% and 46% were observed in regional V T values for method 1, 3 and 4, respectively. For the clinical datasets, visual inspection revealed that motion was no longer visible after correction using these optimal settings. Differences in V T of up to 433% before and after motion correction were found for the clinical data. Moreover, when no motion was present in the original (clinical) dataset, differences in V T before and after motion correction were < 1.5 ± 1.3%, indicating that method 2 can always be used without degrading quantitative accuracy. Conclusions: When no optical tracking system is available or when old datasets have to be reanalyzed, the presented frame-by-frame motion correction method, using the sum of first x frames of nonattenuation corrected PET scans, provides a means to analyse data in which the patient has moved.
Background and aims: Simultaneous measurements of positron emission tomography (PET) and magnetic resonance imaging (MRI) is a promising strategy for direct comparison of functional and morphological information. Therefore, development of PET/MRI is currently on-going for experimental researches and clinical applications. An integrated PET/MRI (iPET/ MRI) system has been constructed that combines an optical fiber based MR-compatible PET with a low magnetic field permanent magnet MRI for small animals. Our aim is to investigate the feasibility of in vivo simultaneous imaging using the iPET/MRI system. Methods: The iPET/MRI system consists of depth-of interaction block detectors made of LGSO, optical fibers (B80 cm), and position sensitive photomultiplier tubes for PET, and radio-frequency coil (j 76 mm) and 0.3T Nd-Fe-B permanent magnet (Hitachi Metal, NEOMAX Co., Ltd) for MRI. To test this system, small animals (Wistar rat, Male, N = 6B) were anesthetized by MR-compatible inhalation device with 1.5% isoflurane and injected approximately 37 MBq of 18 F-FDG with MR contrast medium intravenously. Simultaneous PET (list mode) and MR (fast low angle shot < FLASH > T1-weighted sequence, TR/TE = 50/5 ms) imaging were performed 30 to 90 mins after 18 F-FDG injection. During MRI acquisition, PET data were acquired in 3 axial positions by shifting the PET detector ring to cover B5 cm axial field of view.
Results: 18 F-FDG images showed high uptake in the brain, harderian glands, heart and kidneys, consistent with known distribution. In the cranium and  cervical portions, MR images with contrast medium  provided superior anatomic information such as  cerebral basal ganglia, cerebellum, brainstem, Objectives: Analysis of PET brain data from nonhuman primates (NHP) usually involves registration of PET and MR data. Typically, an early summed PET image (e.g., 0 to 10 mins) provides high contrast between gray and white matter, important for a successful registration. However, kinetics and distribution vary dramatically between tracers, especially in studies involving pharmacological agents. This poses difficulties for PET-MR registrations, where algorithms sometimes fail due to relatively high activity outside the brain within the scanner field-of-view. The aim of this study is to develop a robust, automated method for PET-MR NHP registration for application to a wide variety of PET studies. The approach is to register different time periods of PET data to the MR and select the best transformation.
Methods: Forty-six PET datasets using five tracers were evaluated from rhesus monkey brains, acquired on the high resolution research tomograph (HRRT). T1-weighted MR images (M) were acquired on a 3T scanner, using an extremity coil. The PET-MR intrasubject registration was a two step process. First, the automated image registration (AIR) algorithm was used as an initialization step; this was followed by FLIRT (FSL) using normalized mutual information (NMI) to obtain the transformation. From each dynamic dataset, n = 6 summed PET images, P i , were created using different time intervals: 0 to 10, 0 to 30, 10 to 30, 30 to 60, 60 to 90, and 90 to 120 mins. Using the registration algorithms between M and P i , n transformations (T i ) were determined using each of the images P i . The n transformations, T k , k = 1,y,n, were then applied to each PET summed image, P i , i = 1,y,n, to yield n 2 resliced PET images in MR space, P ik = T k {P i }. Each P ik was masked with a binary image created from the MR image to eliminate outside brain activity. NMI was then computed as a similarity measure between each resliced PET and the MR image due to the transformation applied, i.e., N ik = NMI(M,P ik ) for j = 1,y,n. To choose the optimal transformation, T*, the total NMI score was calculated across PET images (S k = P i N ik ) and T* was chosen as the transformation that provided the best S value. The quality of PET-MR registrations was assessed visually as either good or misregistered. Results: Transforms from all time periods showed some misregistrations: T 0À10 (11%), T 0À30 (4%), T 10À30 (4%), T 30À60 (28%), T 60À90 (37%), and T 90À120 (65%). Low brain uptake (with respect to extra-brain uptake) and noisy images contributed to the poorer registrations. For the new method, the optimal transform T* varied across studies with respect to the selected time interval: T 0À10 (19.6%), T 0À30 and T 10À30 (28.3%), T 30À60 (15.2%), T 60À90 (6.5%), and T 90À120 (2.2%). For all studies evaluated, the chosen transform T* corresponded to an image designated as visually good. Conclusions: A new method for automated PET-MR registration for NHP studies based on NMI measures is proposed, in order to handle the great variability in PET studies with different ligands. This initial evaluation suggests that the method is robust, i.e., no algorithm failures were detected. To further validate this approach, a more extensive quantitative evaluation must be performed with more tracers. Objectives: Primary dystonia is one of genetic brain disorders resulting from dysfunction in the neurotransmission of dopamine D2 receptor systems. Brain imaging with PET has revealed different degrees of loss in striatal D2 receptor availability in subjects with DYT1 and DYT6 genotypes. Many analytical techniques have been proposed to quantify D2 receptor binding with various levels of complexities. The objective of this work was to evaluate the use of simplified approaches to evaluate loss in D2 receptor binding in dystonia gene carriers. Methods: [ 11 C]raclopride (RAC) PET and MR images were acquired from 22 DYT1 gene carriers (age 52 ± 15 yr), 12 DYT6 gene carriers (age 34 ± 16 yr) and 11 normal controls (age 42 ± 16 yr). MR scans were correlated with PET to define striatal volumes of interest (VOI) either manually in the native space or automatically following the spatial normalization into Talairach space. Binding indices in caudate and putamen were measured by distribution volume ratio (DVR) over 30 to 70 mins or striatal-to-occiptal ratio minus 1 (SOR) at 60 mins post injection. Differences in RAC binding among subject groups were evaluated statistically by using parameters computed from different analysis methods. Subject age was included as a covariate in the design of a multivariate general linear model. Results: All analyses showed that striatal RAC binding in the DYT1 and DYT6 groups was reduced compared to normal mean (e.g. Figure 1 ). The reduction in the DYT6 group was 2 to 3 times larger than that in the DYT1 group, with the mean values predicted from the statistical model. DVR values from the manual analysis in the native space revealed that RAC binding decreased in the caudate (F = 4.3; P < 0.02) and the putamen (F = 4.9; P < 0.013). On the other hand, SOR values from the manual analysis demonstrated almost twice as much decrease than DVR in RAC binding in the caudate (F = 19.3; P < 0.0001) and the putamen (F = 18.4; P < 0.0001). In addition, SOR values calculated from the automatic analysis yielded similar results as those from the manual analysis in the caudate (F = 17.8; P < 0.0001) and putamen (F = 18.2; P < 0.0001).
Comparison

Conclusions:
Analyses with different binding parameters and VOI strategies have revealed significant losses in striatal D2 receptor binding in dystonia gene carriers. The striatal-to-occipital uptake ratio obtained from a static frame is more sensitive in discriminating subject groups than the distribute volume ratio from dynamic data acquisition. This simple parameter can be computed automatically in the standard brain space to permit rapid brain mapping analysis on a VOI or voxel basis. This method may be valuable in quantifying topographic evolution in D2 receptor availability in other neuropsychiatric disorders. Objectives: Graphical analyses have advantages in unnecessary for the assumption of the number of compartments and fast computation. However, there is a large noise-induced bias or variability in the estimation of total volume of distribution (V T ). 1 Principal component analysis based method (mPCA) was proposed for a noise reduction in Logan graphical analysis (LGA), 2 which might lead to a deformation of kinetics of time-activity curves (TACs). This study proposes a new noise reduction method for graphical analyses by Karhunen-Loève expansion (mKLE), which aims to maintain kinetics of voxel-based TACs.
Methods: mKLE is based on the assumption that the ratio of a TAC to the input function is approximately constant after a certain time (t*) (transient equilibrium condition). Then the TAC after t* can be represented by one basis function. The basis function is expressed as an axis which passes across the origin and minimizes the distance from TACs in feature space. mKLE was applied to a set of TACs to calculate the basis function. The noise-reduced TACs were obtained by projecting voxel-based TACs onto the basis function. mKLE was tested on human PET data of [ 11 C]TMSX, an adenosine A 2A antagonist radioligand. 3 Dynamic PET scans were acquired for 1 h, and metabolite-corrected arterial input function was obtained. We tested 3 versions: without noise reduction and with mKLE or mPCA. The dynamic data were analyzed by LGA and multilinear analysis (MA1) to calculate the parametric V T images. The regional mean value of V T was calculated from the striatum drawn on the summed PET image. For all graphical methods, t* was set to be 30 mins postinjection. Results: Figure Results: The tangential resolution (FWHM) was about 2.4 mm (r = 0 to 5 cm) in a central transversal plane with r = 0 to 5 cm, whereas radial resolution ranged from 2.1 mm to 5.5 mm. Within the 15 central image planes the axial resolution was 2.5 ± 0.2 mm at r = 0 cm and 3.1 ± 0.2 mm at r = 5 cm. When images of a cylindrical phantom with three cold rods were OSEM3D reconstructed and attenuation corrected, a scatter fraction of 27% was found in the air filled rod. Using a 25 cm long cylinder of 20 cm diameter filled with 18F the peak prompt-minus-delayed count rate was 680,000 cps at 50 kBq/mL. Furthermore, first tests of possible interferences of the BrainPET towards the 3T MRT yielded only minimal changes of the MR performance.
Conclusions: After first promising tests with the 3TMR-PET further detailed tests will be performed and the experiences will be transferred to the 9.4TMR-PET.
503. Highly detailed anatomically accurate 3D brain phantoms for PET with 3D printing Objectives: The quantitative capabilities of positron emission tomography, coupled with targeted radiotracers, are leading to the application of this technology as a neuroimaging biomarker with increasing frequency. Neuroimaging based biomarker studies are now being incorporated into multicenter trials using PET imaging systems with varying intrinsic performance and stability characteristics. Phantom studies are usually performed in order to evaluate the system performance and variability among PET imaging sites used in a given study. An ideal phantom would precisely model the shape and activity distribution of the brain. A commonly used brain phantom is the Hoffman 3D phantom. 1 While this phantom is very well suited for some types of measurements, the apparent activity distribution in the phantom depends on the resolution of the camera making it difficult to use in addressing quantitative issues that require the full resolution of modern PET cameras. Our objective is to develop a method for manufacturing phantoms that accurately model realistic anatomy and are not dependent on imaging system performance.
Methods:
We have developed a method of creating phantoms using rapid prototyping technology (3D printing). The system allows us to create phantoms based on any geometric model, including those derived from high resolution anatomical images. The method consists of incorporated radioactive tracer as a dye in the printing system of a powderbased rapid prototyping system. We use a Z Corp Z510 3D printer [Z Corporation, Burlington, MA]. Printing with 0.18 mm slice thickness at 600 dpi, our custom software allows us to accurately place activity throughout phantom volumes as large as 254 Â 356 Â 203 cm 3 . Software that uses digital atlases as input allows us to specify the activity concentration at the level of individual voxels. Results: Printed activity distributions are linearly variable and reproducible to better than 2%. We have printed and imaged human brain phantoms based on the SPL human brain atlas 2,3 and rat brain phantoms based on the Paxinos and Watson atlas. Objectives: Multipoint arterial blood sampling after radiotracer injection is usually required for precise quantification on PET study. When multiple scans are required in the same animal, however, the number of blood sampling is limited because of small blood volume in animals. In this study, we developed a new tracer injection method to apply the H 2
15
O steady-state (SS) method which needs only a few blood sampling points to measure cerebral blood flow (CBF). Methods: We designed a program for H 2 15 O injection combining bolus and slowly increscent (B/I) injection manner to reduce time for achieving an equilibrium of blood radioactivity in the H 2 15 O SS method. In this program, H 2 15 O was injected rapidly for 45 secs to fill the dead volume of injection tube and increase blood radioactivity, followed by gradual administration to compensate decay of 15 O radioactivity in the blood. Efficacy of the program of H 2 15 O B/I injection to achieve fixed radioactivity was evaluated using a dose meter. Then, eight rats were studied with a small animal PET scanner. Small catheters were inserted into the femoral artery for blood sampling and the femoral vein for H 2 15 O administration. Before emission scans, a transmission scan was performed for 60 mins using 68 Ge/ 68 Ga. Six-minute list-mode PET scans were initiated at intravenous administration of 555 MBq/mL H 2 15 O using the B/I injection program with the syringe pump. Arterial blood was sampled every 1 mins during PET scans. Fifteen minutes after the H 2 15 O PET scan, N-isopropyl-p-[ 125 I]-iodoamphetamine ( 125 I-IMP) was injected in the same rat and arterial blood was withdrawn at a constant rate for 10 mins after tracer administration using the syringe pump. The rat brain was immediately removed and exposed to imaging plate for autoradiography. We selected similar 3 slices from H 2 15 O PET and 125 I-IMP autoradiography images. Regions of interest (ROIs) were placed at whole brain on the slices in each radiotracer image. CBF from H 2 15 O SS method and that calculated from 125 I-IMP-autoradiography based on microsphere model were compared. Results: The radioactivity of H 2 15 O administered by the B/I injection program achieved equilibrium at approximately 20 MBq in a dose meter. In the rat study, radioactivity concentration of H 2 15 O rapidly achieved equilibrium in the blood and brain at apploximately 2 mins after administration (Figure) . Correlation of the CBF values of H 2 15 O (48.6±5.8 mL/ 100 g/min) using SS method and those of 125 I-IMP (48.8 ± 5.8 mL/100 g/min) was excellent (y = 0.99x + 0.21, R 2 = 0.98). Conclusion: The SS method with the B/I injection is useful for CBF measurement on small animal study and can be applied for animal and human PET studies using many radiotracers with short half life. 
Template based attenuation correction for brain MR-PET scanners
E. Rota Kops and H. Herzog
Institute of Neuroscience and Medicine, Forschungszentrum Juelich, Juelich, Germany
Objectives: A primary prerequisite that positron emission tomography is regarded as a quantitative imaging procedure is its ability to correct sufficiently for attenuation. While in dedicated PET scanners attenuation correction is usually based on measured transmission data, in the new combined MRI-PET scanners the attenuation coefficients must probably be obtained with help of the anatomical T1-weighted images. This work investigates template based attenuation correction (TBA) of PET scans, the procedure of which was described in a previous report, 1 in comparison to conventional PET based attenuation data (PBA). Methods: Several templates were created. Inputs for these templates were gender specific attenuation maps recorded by PET transmission scans as well as a female CT image converted into linear attenuation coefficients in cm À1 at 511 keV. 2 For the gender specific attenuation maps we used four male and four female transmission images and registered nonlinearly three of them to the fourth. Furthermore, we took all eight images and registered non-linearly seven of them to a male eighth or to a female eighth. Finally, averages of these four registered groups were calculated resulting in four transmission based attenuation templates txAT (4mAT and 4fAT, 8mAT and 8fAT), for which the corresponding MR templates were obtained in the same way. The converted female CT image and its corresponding MR image built a CT based attenuation template (ctAT). Following the procedure described elsewhere, 1 PET scans of 5 male and 5 female subjects of an ongoing study were attenuation corrected using the five groups of ATs and the reconstructed emission data were compared to PET images which were attenuation corrected using the conventional PBA data. Regions of interest (ROI) were drawn in cortical and subcortical relevant areas. Relative differences between PBA and the TBA images were calculated and averaged over all ROI and over each group. Results: While in case of ATs, which have been created by referring to a female image, the means were positive with very similar standard deviations (4fAT: 1.04± 3.73%, 8fAT: 0.13 ± 3.57%, ctAT: 1.86 ± 3.50%), the corresponding values obtained with ATs, which have been referred to a male image, showed a slight underestimation (4mAT: À2.84 ± 3.63%, 8mAT: À2.46 ± 3.52%). Between the mixed gender (8fAT: 0.13 ± 3.57% and 8mAT: À2.46±3.52%) and the genderrelated templates (4fAT: 1.04±3.73%, 4mAT: À2.84± 3.63%, and ctAT: 1.86 ± 3.50%) no significant differences could be found. Conclusions: The presented results show that the mixed gender templates (8fAT and 8mAT) as well as the gender-related templates (4fAT, 4mAT, and ctAT) are appropriate for attenuation correction in a MR-BrainPET scanner.
Objectives: To investigate the effects of partialvolume (PV) correction on the discrimination between Alzheimer's disease (AD) patients and healthy aging controls (HC) using novel amyloid imaging candidate [11C]-AH110690. 1 Methods: The effect of partial-volume correction (PVC) was assessed using data from a previously acquired study. Nine AD patients and nine HC underwent a baseline and 12-month [11C]-AH110690 PET scan (Siemens ECAT EXACT HR + ) and T1 MRI.
PV correction was applied using the Van-Cittert (VC) iterative deconvolution technique. A positioninvariant point spread function (PSF) of 5.1 mm fullwidth at half-maximum (FWHM) was used for PVC, based on measurement.
Standardised Uptake Value Ratio (SUVr) images of both the PV corrected and uncorrected data were created by normalising summed images (50 to 70 mins post-injection) using cerebellar grey matter as a reference region. The summed images were rigidly registered to the patient MR and spatially normalised to Montreal Neurological Institute (MNI) space. The summed images were then warped to MNI space using the parameters from the MR-MNI normalisation and smoothed by 8 mm. Statistical Parametric Mapping (SPM5) analysis was carried out on the cohort. Two-sample t-tests, AD > HC, were performed on the uncorrected and PV corrected data. P-values were corrected for multiple comparisons using False Discovery Rate (FDR) (P = 0.03) with an extent threshold of k = 25 voxels. Results: The VC deconvolution tends to amplify noise during subsequent iterations of the scheme. All images reached the stopping criteria at 30 iterations or fewer. Partial volume correction for each of the PET images of matrix size 128 Â 128 Â 63 took less than 2 mins on an AMD Athlon XP 1700 + with 1792MB RAM and running Windows XP.
The SPM group analysis between Alzheimer's patients and control subjects detected significant clusters in the frontal (No-PVC P = 0.021, PVC P = 0.016) and parietal lobes (No-PVC P = 0.018, PVC P = 0.014). Both clusters increased in size after PVC (frontal + 9.03%, parietal + 3.26%). The total number of clusters detected increased from 25 to 37 with PVC. Conclusions: This work has shown that the application of partial-volume correction increases the spatial extent of significant clusters using SPM analysis. The appearance of small clusters in the PV corrected image, absent from the uncorrected image, suggests that PV correction improves discrimination. 1 In subsequent studies the compound is referred to as GE-067.
Accurate measurement of arterial input function during FDG PET using a beta microprobe
G. Warnock 1 , C. Lemaire 1 , X. Langlois 2 , A. Luxen 1 and A. Plenevaux 1 binding using radioligands. The usual method for determining input function is manual blood sampling at specific time points followed by counting of the radioactivity in a given volume. However, the measurement of input function via arterial blood sampling generally has poor time resolution and can lead to significant blood loss in small rodents.
Beta microprobe systems have recently become commercially available as an affordable alternative to PET. These systems utilise implantable probes consisting of a small (0.25 to 1 mm) scintillation crystal bonded to a fibre optic cable, which can be stereotactically located in a specific region of the rodent brain. Scintillation in the crystal is carried by fibre optic to a photomultiplier tube from which a timeactivity curve is generated.
Pain et al 1 used two beta microprobes to measure input function with one probe directly in the femoral artery. However, in this method the activity in surrounding tissues influenced the accuracy of the input function. Weber et al 2,3 used an arteriovenous shunt and coincidence counter to measure input function while using beta microprobes in the brain. We have combined these two techniques to accurately measure FDG input function with high temporal resolution (1 secs) and no loss of blood. Using our apparatus a beta microprobe is placed directly in the blood flow of an arteriovenous shunt. The bi-exponential conversion for FDG described by Weber et al 2, 3 can then be used to generate the arterial plasma input function. Via the shunt it is also possible to infuse tracer or treatment compounds, and to continuously measure blood pressure.
We have used our apparatus to measure input function in beta microprobe studies of the brain, and furthermore have combined the measurement of input function in this way with PET scanning in rats. Our method for the measurement of input function will be extended to further studies with additional radioligands. Thus, kinetic modelling can be carried out without the need for a reference region or less accurate estimation of input function. Our goal is to compare and validate several different techniques for measuring quantitative regional cerebral blood flow (rCBF) using a simultaneous PET/MRI system in rats. This synthesis of existing technologies raises new pragmatic concerns. Due to space limitations we could not use a standard animal RF coil and head holder. Using an eight section birdcage RF coil schema, we constructed a system that integrates into the RF coil the necessary PET requirements and a stereotactic device that will reliably and repeatably position the rat brain with respect to the PET insert. Methods: The RF coil is made of acrylic tubing, 51 mm OD, 44 mm ID, and 56 mm in length. Blunt and tapered 6 mm threaded rods serve as ear bars. 19 mm slots were cut into the coil allowing a U-shaped tooth bar holder to be fixed in place. A 17 mm wide tooth bar adjusts to fit the subject and can be locked in place by a screw at the bottom of the U of the tooth bar holder. In an effort to limit positron annihilation photon attenuation caused by the RF coil, minimal material was used throughout construction.
Because the position sensitive avalanche photodiodes (PSAPD) of the PET insert need to be kept at À101C for optimal performance, we designed an insulated body holder to keep the subject at 371C. To accomplish this, the body holder will shield the subject from the cooling system for the PSAPD while allowing for warm air to be blown on the subject. The body holder will be comprised of two half-cylinders that can be securely fitted together during the scan. This design allows for easy set up and positioning of the subject and the lines running to and from the subject. Results: Initial scans were performed on a 4.7T (300 MHz) Varian MRI scanner (Palo Alto, CA). A 33 mm diameter 30 mL cylindrical saline phantom was scanned to demonstrate good coil uniformity and signal to noise ratio. In vivo scans of a rat brain were performed and uniformity was verified using a flip angle calibration method. From these results, we expect the RF coil to provide good coverage of the rat brain and accurate quantitative imaging results. Conclusion: We have constructed an integrated RF coil/head stereotactic device and are working on a body holder that meets the unique requirements of simultaneous PET/MRI studies. Phantom scans have demonstrated the reliability and effectiveness of our design. Future work will include incorporation of PET/MRI fiducials and heating of the subject. Objectives: An important advantage of positron emission tomography (PET) relative to other functional imaging methods is its capacity for quantification in physiological units. For physiological quantification, the arterial-radiotracer concentration must be measured throughout the tracer-uptake period. Typically, this is done by sampling the arterial blood during scanning, to obtain an arterial input function (AIF). The goal of this study was to validate use of an intra-arterial b + probe for measuring the AIF in humans. In a within-subject design, AIFs obtained via a b + probe placed in the radial artery were compared to AIFs obtained by dynamic imaging of the descending aorta. Methods: Eight healthy, normal volunteers participated. Each subject underwent 12 PET scans (6-thorax; 6-brain) and 2 MRI scans (1-thorax; 1brain). Thoracic images were used to obtain intraaortic AIFs. For each PET scan, 555 MBq of H 2 15 O in 6-mL saline was injected as an intravenous bolus. Image acquisition consisted of 90 two-sec frames, beginning B20 secs before injection. MRI was used to determine aortic diameter and location. Aortic ROIs created on MRI images were transferred to PET images for AIF. From the ROI, an aortic AIF was obtained. The aortic ROI values were corrected for partial volume effects using the recovery coefficient method. Radial AIFs were obtained using a b + probe fabricated in-house. 1 The probe consists of a 0.5-mm-diameter plastic scintillating fiber coupled to a photosensor module and was placed in the radial artery via a 22-gauge catheter. Intraarterial b + -probe counts were corrected for gamma interactions using an identical external probe attached to the wrist. Both b + probes were sampled at 1 Hz. The time-delay between the aortic and radials AIFs was measured and then corrected for prior to statistical comparison of the two AIFs. Full-width half maximum (FWHM), peak amplitude, area and correlation coefficient were used to characterize and compare the radial and aortic AIFs. Results: Good-quality radial (circles) and disperse-corrected aortic (triangles) AIFs were successfully obtained for every injection in every subject (Figure) . The time delay between the disperseuncorrected aortic (solid-lines) and radial bolus arrival times was 19.6 secs ( ± 1.8 secs, SD). AIFcurve shapes were appropriate for a rapid bolus injection and frame-to-frame variability (noise) was very low. Radial AIFs were more dispersed than aortic AIFs. After delay and dispersion correction, the shapes of the two AIFs curve did not differ. This was statistically confirmed (paired-t test) by comparing the FWHMs (P = 0.401), peak amplitudes (P = 0.889), and areas under the curves (P = 0.401), none of which differed. The correlation between the aortic and radial AIFs was excellent (r = 0.90 ± 0.07 (mean ± s.d.)).
Conclusion: An intra-arterial b + probe is reliable, low-noise, high-temporal-resolution, method for obtaining an AIF for PET quantitative. Objectives: An important advantage of positron emission tomography (PET) relative to other functional imaging methods is its capacity for quantification in physiological units. For physiological quantification, the arterial radiotracer concentration must be measured throughout the tracer uptake period. Typically, this is done by sampling the arterial blood during scanning, to obtain an arterial input function (AIF). As an alternative to blood extraction, we have developed an intra-arterial, positron-detecting probe (b + probe) system for measuring the AIF. 1 The goal of this study was to demonstrate the use of the b + probe system for H 2
15
O PET studies in humans. In a within-subject design, H 2 15 O PET measurements of cerebral blood flow (CBF) were obtained during normal ventilation and volitional hyperventilation, a maneuver know to lower whole-brain CBF. Methods: Eight healthy, normal volunteers participated. Each subject underwent 12 PET scans (6 thorax; 6 brain) and 2 MRI scans (1 thorax; 1 brain). Thoracic images were used to validate the b + probederived AIFs relative to aortic, image-derived AIFs (reported in a separate abstract 2 ). Brain images were used to compare brain blood flow in the two physiological states. For each H 2 15 O PET scan, 555 MBq of H 2 15 O in 6 mL of saline was injected as an intravenous bolus. For the six brain scans, physiological state was alternated between normoventilation and hyperventilation. Radial artery AIFs were obtained using the b + probe system, which consists of a 0.5 mm-diameter plastic scintillating fiber coupled to a photosensor module (Hamamatsu, H7826P) via a luer-lock hub. The probe fiber was placed in the radial artery via a 22-gauge catheter. Intra-arterial b + probe counts were corrected for gamma interactions using an identical external probe attached to the wrist. Both b + probes were sampled at 1 Hz. Global CBF (mL/100 g/min) was calculated using the Ohta method. 3 CBF values were computed with and without dispersion correction using twosample pair t-tests. Results: Values for whole-brain CBF were in excellent agreement with literature values 3 for both physiological states, both with and without dispersion correction. In normal ventilation, whole-brain CBF values were 51.7 ± 7.7 (mean ± s.d.) uncorrected and 50.6 ± 6.8 corrected, which were not significantly different. In hyperventilation, whole brain CBF values were 35.6 ± 4.8 (mean ± s.d.) uncorrected and 34.0 ± 4.8 corrected, which also were not significantly different. As expected, hyperventilation dramatically lowered whole-brain CBF, this change being highly significant (P < 0.0002). Conclusion: Physiologically quantitative PET studies can be obtained using an intra-arterial, positrondetecting probe system to obtain the arterial input function. This internal tracer quantification method is safer, simpler and more convenient than methods which rely on external counting of blood samples removed from the subject. Dispersion correction of AIFs obtained by this method is not necessary. 925. A brain phantom study of iterative deconvolution versus anatomical-based partial-volume correction techniques Objectives: Partial-volume (PV) correction techniques require a measure of the scanner point-spread function (PSF) to operate. Two anatomical-based partial-volume correction (PVC) methods were evaluated: Mü ller-Gärtner (MG) and Multi-target correction (MTC). An iterative deconvolution method, Van-Cittert (VC), that requires no anatomical data, was also applied. The objective is to evaluate whether the performance of Van-Cittert deconvolution is comparable to anatomical PVC techniques when faced with measurement errors and noise. Methods: Synthetic phantom images were generated using the Zubal phantom in Matlab with a 4:1 grey matter (GM) to white matter ratio. 10% variability in regional GM concentrations was applied. The image was forward projected with attenuation, adding approximations for scatter and randoms. Poisson distributed noise was added to the sinograms. Reconstruction was performed using filtered backprojection (FBP) with a Ramp filter. Ten realisations were generated at each noise level. Images were analysed in terms of recovery coefficient (RC) and standard deviation (s.d.) across noise realisations. A position-invariant PSF of 7.75 mm was found by measurement.
MG and MTC were executed in Matlab. The VC method was implemented in C + + and uses a Deriche-style recursive approximation Gaussian filter. MTC is a 'hybrid' anatomical PVC method, performing a Geometric Transfer Matrix (GTM) PV correction and using the estimated regional values as a basis for voxel-based PV correction. PVC was executed with PSF errors of ± 2 mm (5.75 to 9.75 mm). MG and MTC PV correction was per-formed with perfect VOIs. Five count levels were tested (1.20e + 07 to 3.84e + 08). Introduction: A sophisticated 3-dimensional brain phantom simulating a realistic head model that contains bone and detailed grey matter structures has been developed. Adequacy of the lasermodeling technique for constructing a detailed structure and its usefulness for evaluating a partial-volume effect (PVE) has been tested for PET/SPECT imaging. Materials and methods: The phantom was made of transparent photo-curable polymer of density 1.09 g/ mL, and constructed with the laser-modeling technique. The grey matter structure was designed sliceby-slice by tracing a high-resolution MRI on a healthy volunteer, consisting of cortical grey matter regions, striatum, thalamus, and the cerebellum. Additional component was made for skull structure, to which bone-equivalent solution of K 2 HPO 4 was inserted. These multiple slice images were combined to establish two volume compartments, in which axial interpolation was made carefully so that each component does not lose connection. This volume data was then deformed 3-dimensionally to fit to a mannequin head model. Careful attention was made so that the liquid can be diluted to each component without air-bubble contamination. X-ray CT images were acquired to confirm the design structure, and also the bubbles not being contaminated. PET images were then acquired using Siemens ACCEL tomograph with F-18. A sophisticated program for correcting for the partial-volume effect, PVElab 1 has been applied, and the accuracy of the correction was tested.
Results
Results and discussion: The volume of the greymatter component was 550 mL, and the bone 250 mL. The apparent attenuation coefficient for the whole brain was 0.173 cm-1 for Tc-99m, slightly higher than typical values for normal volunteers (0.168 cm À1 ). Air bubbles have been removed relatively easily from each of compartments, as confirmed with the X-ray CT. X-ray CT also demonstrated a good agreement with the original design of the phantom, suggesting adequacy of the laser-modeling technique. PET images also showed a good agreement with the design after smoothing. The pixel counts in the grey matter area, which varied from region to region, became closer after the PVE correction, as shown in Figure. Counts in frontal and temporal regions relative to striatum was 0.92 and 0.89, which became 0.96 and 0.92, respectively. However, counts in the occipital, parietal, cerebellum regions did not show improvement after PVE correction, which might partly be attributed to misalignment between PET and the anatomical image. Conclusion: Use of the realistic 3D-brain phantom may be an adequate approach for evaluating accuracy of various PVE correction techniques in brain PET. Objectives: To present a methodological platform for effective connectivity analysis for positron emission tomography (PET) or functional MRI (fMRI). It works with an input dataset composed from the activation time course of specific brain regions for several subjects under study and gives as outputs the estimation of the connectivity coefficient between the regions, the corresponding P-values, the regression coefficients and the acceptance value of the FDR and the Hochberg tests for the significance level of the connectivity detected. Methods: Partial correlation has been considered as an effective measure of functional connectivity between a given pair of brain regions by removing the effects caused by other regions (Marrelec, 2008) . We combined data from two studies of focal activation in response to the different conditions, which had two identical conditions, the implicit processing of passages of narrative speech and their spectrally-rotated (unintelligible) transformations. The partial correlation values were calculated using a fixed effect model whereas one regional data-point was extracted from each PET [O 15 ]water PET and all scans for all subjects were pooled together in the same data matrix.
Individual regional values were normalized to the global brain radioactivity; this was achieved by using the average of brain counts as additional variable in the partial correlation analysis. Partial correlation coefficients were then transformed in normal z-scores using the Fisher z-transform. The ensuing set of Pvalues was thresholded using the false positive rate correction (0.05 false positive rate) calculated using the adaptive methodology detailed in Benjamini and Hochberg 1 that used an estimator of the number of true null hypothesis presented in (Turkheimer et al. 2 ).
Results: The pattern of connectivity indicated that the angular gyrus exerts top-down influence over activity within the part of the language network distributed across left posterior temporal cortex, contrary to other influential models of speech comprehension. In addition, there were also anterior temporal lobe functional connections, incorporating top-down influence from the anterior part of Broca's area in the inferior frontal gyrus; and between a number of mirror regions in the left and right cerebral hemispheres.
Conclusions: This work demonstrates that the partial correlations between pairs of brain regions can be a useful tool for effective connectivity analysis. This allows the effect of other nodes in the network to be subtracted (as well as removing the effect of nuisance factors such as global radioactivity counts), leaving a more accurate approximation of the interaction between pairs of regions. Availability: The software is available free for academic use upon request.
a dynamic scan conducted in a ECAT HR + after injection of 370 MBq of [ 11 C]ABP688 IV followed by a 15 mins transmission scan. Images were reconstructed using filter back projection and subsequently analyzed using the Logan's reference tissue method with the cerebellum as a reference region. All participants had a T1 weighted 1 mm isotropic MRI for coregistration purposes. Individual PET-MRI images were linearly registered using rigid body transformation. The MRIs were then linearly registered to the MNI157 space using 9 parameters. The PET images subsequently underwent a nonlinear registration using a deformation field to warp the image to the best possible fit. Patients with right TLE had their PET flipped in the x-direction prior to registration in order to keep the epilepsy hippocampus in the left side. T-statistics were calculated by comparing the left hemisphere of TLE patients versus Ctrls with linear and nonlinear registration.
Results: Unilateral abnormalities in the epileptogenic hippocampus of TLE patients could be clearly identified with both linear and nonlinearlytreated images, with significant declines of [ 11 C]-ABP688 BP ND (t (linear) = 6.6 as compared to t(nonlinear) = 5.6). However, nonlinearly registered maps could identify the maximum peak within subiculum-CA1 regions, whereas linearly registered images showed a more homogeneous cluster involving the whole hippocampal head. Hippocampal cluster peaks were 5 mm apart and maximum t-value was higher for linearly coregistered maps (6.6 as compared to 5.6). No difference in cluster extent was observed (voxels of t > 3.0 within the hippocampal clusters: 2906 versus 2896). Conclusions: In TLE, we were able to show that in a group of patients with structural abnormalities involving small and complex structures such as the hippocampal formation, linear registration might bias the anatomical location of PET information. In the particular case of TLE, receptor binding studies such as [ 11 C]ABP688-PET can provide detailed information that can be later correlated with pathological findings of cell loss and gliosis within specific hippocampal subfields.
